- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
90 Neuroma Trials Near You
Power is an online platform that helps thousands of Neuroma patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerRavulizumab for Neuromyelitis Optica Spectrum Disorders
Trial Details
Key Eligibility Criteria
58 Participants Needed
Suzetrigine for Diabetic Neuropathy
Trial Details
Key Eligibility Criteria
300 Participants Needed
BXQ-350 for Colorectal Cancer
Trial Details
Key Eligibility Criteria
195 Participants Needed
Cell Therapy for Duchenne Muscular Dystrophy
Trial Details
Key Eligibility Criteria
104 Participants Needed
Gene Therapy for Hearing Loss
Trial Details
Key Eligibility Criteria
14 Participants Needed
Brain Imaging for Juvenile Fibromyalgia
Trial Details
Key Eligibility Criteria
80 Participants Needed
Gene Therapy for Congenital Hearing Loss
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
104 Participants Needed
Trial Details
Key Eligibility Criteria
8 Participants Needed
Mirvetuximab Soravtansine for Ovarian Cancer
Trial Details
Key Eligibility Criteria
100 Participants Needed
Sugammadex vs Neostigmine for Neuromuscular Blockade
Trial Details
Key Eligibility Criteria
80 Participants Needed
Reversal Agents for Postoperative Urinary Retention
Trial Details
Key Eligibility Criteria
286 Participants Needed
VX-993 for Diabetic Neuropathy
Trial Details
Key Eligibility Criteria
300 Participants Needed
Electrical Stimulation for Diabetic Neuropathy Pain
Trial Details
Key Eligibility Criteria
60 Participants Needed
ARGX-117 for Multifocal Motor Neuropathy
Trial Details
Key Eligibility Criteria
51 Participants Needed
Nerve Stimulation for Diabetic Neuropathy
Trial Details
Key Eligibility Criteria
15 Participants Needed
Patisiran for Cardiomyopathy
Trial Details
Key Eligibility Criteria
360 Participants Needed
Vutrisiran for Transthyretin Amyloidosis with Cardiomyopathy
Trial Details
Key Eligibility Criteria
655 Participants Needed
Genital Nerve Stimulation for Spinal Cord Injury
Trial Details
Key Eligibility Criteria
12 Participants Needed
Reduced-Dose SABR for Prostate Cancer
Trial Details
Key Eligibility Criteria
124 Participants Needed
Why Other Patients Applied
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
Neuromechanical Gait Assist for Stroke Recovery
Trial Details
Key Eligibility Criteria
5 Participants Needed
Axoguard Nerve Protector for Cubital Tunnel Syndrome
Trial Details
Key Eligibility Criteria
20 Participants Needed
Closed-Loop Spinal Cord Stimulation for Chronic Pain
Trial Details
Key Eligibility Criteria
25 Participants Needed
LY3556050 for Diabetic Peripheral Neuropathic Pain
Trial Details
Key Eligibility Criteria
410 Participants Needed
Botox for Neuropathic Pain
Trial Details
Key Eligibility Criteria
10 Participants Needed
Inebilizumab for Neuromyelitis Optica
Trial Details
Key Eligibility Criteria
30 Participants Needed
Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain
Trial Details
Key Eligibility Criteria
222 Participants Needed
Pregabalin + Duloxetine for Peripheral Neuropathy
Trial Details
Key Eligibility Criteria
190 Participants Needed
Fish Oil + Salsalate for Diabetic Neuropathy
Trial Details
Key Eligibility Criteria
100 Participants Needed
IVIG for Small Fiber Neuropathy
Trial Details
Key Eligibility Criteria
20 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Neuroma clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Neuroma clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Neuroma trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Neuroma is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Neuroma medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Neuroma clinical trials?
Most recently, we added Gene Therapy for Charcot-Marie-Tooth Disease, Satralizumab for Neuromyelitis Optica Spectrum Disorder and Pregabalin + Duloxetine for Peripheral Neuropathy to the Power online platform.